Atlas Trials

Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis

Clinical trial NCT05486104 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05486104
Sponsor
Ganzhou Hemay Pharmaceutical Co., Ltd
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Moderate to Severe Ulcerative Colitis
Start date
2022-11-08
Primary completion
2026-12-30
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.